Gimv

Gimv is a European investment company based in Antwerp, Belgium, with over 30 years of experience in private equity and venture capital. Founded in 1980, the firm focuses on a diverse range of sectors, including business-to-business services, financial services, healthcare, information technology, technology, media and entertainment, telecommunications, manufacturing, and life sciences. Gimv operates primarily in Belgium, France, Germany, the Netherlands, and Switzerland, managing approximately 1.8 billion EUR in investments across 85 portfolio companies. These companies collectively generate over 6 billion EUR in turnover and employ more than 28,000 professionals.

Guillaume Bardy

Partner

Ronald Bartel

Partner

Alexandre Brestin

Associate, Smart Industries

Vande Capelle, Kristof

CFO

Caron, Anne

Partner

Koen Dejonckheere

CEO

Bart Diels

Managing Partner - Head Health and Care

Martin van Dieten

Analyst

Pierre Egot

Principal

Patrick Franken

Partner, Consumer

Philipp von Hammerstein

Partner

Mathieu Himpe

Principal

Andreas Jurgeit Ph.D

Partner, Life Sciences

Hidde Van Kerckhoven

Principal

Elderd Land

Partner

Gautier Lefebvre

Principal

Erik Mampaey

Managing Partner

Maja Markovic

Principal

Nick Medaer

Partner

Stéphane Mircich

Principal

Ruben Monballieu

Partner

Rombout Poos

Finance Director and Business Analyst

Christophe Van Quickenborne

Partner

Morgane Renault

Principal, Consumer

Tom Roth

Associate, Connected Consumer

Patrick Schaich

Principal

Catharina Soenen

Principal, Sustainable Cities

Elsa Spangenberg

Associate, Healthcare

Eline Talboom

Business analyst

Muriel Uytterhaegen

Principal, Smart Industries

Eric de La Vigne

Principal

Tom Van de Voorde

Managing Partner - Head of Smart Industries and member of Investment Committee

Kalle Wanner

Principal, Sustainable Cities

Wirtz, Boris

Principal

Nicolas de Saint Laon

Partner

Past deals in Benelux

BioConnection

Secondary Market in 2022
BioConnection is a European company specializing in the development and manufacturing of injectable biopharmaceutical products. It offers contract manufacturing services to small biopharmaceutical companies, providing access to both small-scale clinical batch production and large-scale commercial manufacturing facilities. The company is equipped with filling and freeze-drying technology and supports clients with sterile drug product development, process validation, and analytical services. BioConnection's extensive network of skilled suppliers and collaborators, including partnerships with experienced organizations, enhances its ability to deliver reliable solutions for clients focusing on personalized medications and clinical trials. By serving as an independent intermediary, BioConnection simplifies the process for companies that may lack the resources or expertise for comprehensive clinical development, ensuring efficient product delivery without the need for clients to seek multiple vendors.

Precirix

Series B in 2022
Precirix is a biotechnology company based in Brussels, Belgium, focused on developing radio-immunotherapeutic drugs for cancer treatment. The company's innovative approach leverages the camelid immune system, utilizing antigen-binding fragments to deliver therapeutic radioisotopes directly to targeted receptors on cancer cell surfaces. This targeted delivery system aims to provide personalized cancer therapies, enhancing treatment efficacy while minimizing side effects. Precirix is actively engaged in clinical development, particularly for cancers that express HER2, and is exploring compounds for various other cancer indications. Established in 2014, the company is committed to advancing a new generation of targeted cancer therapies.

Onward

Venture Round in 2021
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Verkley

Acquisition in 2021
Verkley is a company focused on constructing and maintaining underground cable and pipeline networks for various sectors, including energy, water, telecommunications, and industrial applications. It provides a range of services, including the laying, mounting, and testing of cables and pipes for gas, water, electricity, heating networks, and public lighting. By leveraging its expertise, Verkley assists clients in optimizing their infrastructure while minimizing waste and reducing environmental impact. The company serves a diverse clientele that includes network companies, industrial firms, and government entities.

Televic

Acquisition in 2020
Televic specializes in providing advanced communication systems tailored for specific markets, including healthcare, education, railways, and conferences. The company manufactures a range of products such as digital on-board services networks, passenger information systems, visual information solutions, rail information systems, and entertainment systems. These offerings ensure seamless and interference-free communication, enhancing user experience in various settings. Televic's commitment to high-tech and high-quality solutions positions it as a leader in its sector, while its strategy to diversify shareholding aims to support further global expansion and strengthen its market presence.

AME

Private Equity Round in 2020
AME is an independent developer and manufacturer of high quality electronic products located in the top technological region.

iSTAR Medical

Series C in 2019
iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium. By 2012, iSTAR received ISO 13485 and ISO 9001 Quality Systems Certifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant.

Biotalys

Series C in 2019
Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.

Alro group

Acquisition in 2019
The Alro Group is a specialises in coating of plastic and metal parts for the automotive sector. Alro Group grown from a small coating company to a large reputed group with several branches in Western and Central Europe, specialized in coating of plastic and metal parts for the automotive sector.

Precirix

Series A in 2018
Precirix is a biotechnology company based in Brussels, Belgium, focused on developing radio-immunotherapeutic drugs for cancer treatment. The company's innovative approach leverages the camelid immune system, utilizing antigen-binding fragments to deliver therapeutic radioisotopes directly to targeted receptors on cancer cell surfaces. This targeted delivery system aims to provide personalized cancer therapies, enhancing treatment efficacy while minimizing side effects. Precirix is actively engaged in clinical development, particularly for cancers that express HER2, and is exploring compounds for various other cancer indications. Established in 2014, the company is committed to advancing a new generation of targeted cancer therapies.

Kind Technologies

Venture Round in 2018
Kind Technologies specializes in industrial automation for greenhouse horticulture, focusing on enhancing the efficiency of greenhouse growers and packing centers. The company employs advanced technologies such as computer vision and robotics to develop systems for internal logistics, sorting, packing, and inspection. By implementing these innovations, Kind Technologies enables its clients to increase agricultural yields, minimize waste, and manage the growth of fruits, vegetables, and plants more predictably and sustainably.

Impact

Acquisition in 2018
Impact is a temporary employment agency for specialists in technics, construction and office work. IMPACT is a specialized temporary employment agency with its headquarters in Hasselt. Their main objective? By means of a personal approach, a clear focus, and a great deal of engagement and expertise, they aim to match employers with specialists who are looking for a job in the fields of technics, construction, or office work. Thus, they contribute to the successful growth of enterprises and to the professional satisfaction of the experts who found a job thanks to them.

Cegeka

Venture Round in 2017
Cegeka is an information technology company that specializes in providing a range of services aimed at facilitating digital transformation for businesses. Their offerings include cloud computing, cybersecurity, software development, application management, and data solutions. Additionally, Cegeka provides digital workplace and end-user management services, allowing organizations to optimize operations and improve collaboration with customers and partners. Through their comprehensive suite of tools and integration services, Cegeka supports businesses in navigating the complexities of a rapidly evolving digital landscape, ultimately helping them enhance their competitive edge.

Arseus Medical

Private Equity Round in 2017
Arseus Medical is a distributor of medical equipment and consumables focused on serving hospitals, specialists, nursing homes, and home healthcare providers. The company emphasizes efficient diagnostic and therapeutic solutions, offering a range of products including sterile medical gloves, incontinence materials, wound care items, and small instruments. Arseus Medical supports healthcare professionals with systems for patient monitoring and treatment in various care settings, both inside and outside hospitals. By providing innovative solutions and high-quality resources, the company aims to enhance the efficiency and effectiveness of medical practices, allowing professionals to concentrate on patient care. With a strong presence in the Benelux region and dedicated teams, Arseus Medical distinguishes itself through exclusive distribution agreements and a commitment to delivering value to its clients.

ALT Technologies

Acquisition in 2017
ALT Technologies, established in 1935, is a prominent manufacturer of critical airbag components, specializing in covers, wraps, and seals. The company serves nearly all major airbag producers, securing multi-annual contracts that ensure its products are integrated into a wide range of well-known automobile brands globally. In addition to its airbag component production, ALT Technologies also produces tailor-made die-cut and self-adhesive products for various sectors, including automotive and durable goods. The company utilizes materials such as stainless steel and non-woven plastics to deliver innovative and cost-effective solutions that address evolving customer needs in developing new product lines.

Biotalys

Series B in 2017
Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.

Itineris

Venture Round in 2017
Itineris specializes in developing and implementing UMAX, a cloud-based customer information and customer relationship management solution tailored for the utilities sector. UMAX utilizes workflow automation and artificial intelligence to facilitate comprehensive management of utility operations, encompassing functions such as revenue collection, asset management, and customer engagement. Built on the Microsoft Dynamics 365 platform and hosted in the Microsoft Azure Cloud, UMAX aims to streamline business processes for utility professionals. Since its founding in 2003, Itineris has established a strong track record in implementing its solutions across various clients, including notable organizations such as De Watergroep in Belgium, Eneco in the Netherlands, and the New York Department of Environmental Protection in the United States. The company focuses on empowering utility professionals to adapt to the evolving landscape of energy and water management.
Riaktr is a Belgian scale-up founded in 2009 and backed by first class investors (Fortino, Endeit, GIMV). We started as a service company under the name ‘Real Impact Analytics’. At the time, Big Data was the new big thing, driving important corporate investments. Yet, too often such investments were not yielding the desired returns. Since day one, we pursue a clear mission: leverage the value of telecom data. We do this by starting from the field to build user-centric frameworks driving results. We resist the ‘black box’ principle by putting data at the service of human intelligence and bringing teams together under a collaborative approach. Our brand Riaktr, adopted in 2018, symbolizes our pivot from a services business to a product company. Today our software products address two major questions faced by telcos: - How can I optimize my network CAPEX investments? - How can I optimize my Sales & Distribution operations? Behind the scenes, we are a team of computer scientists, engineers and business consultants based in the heart of Brussels, with a local presence close to our clients in South-Africa and Brazil. We have worked in many countries in Africa, Latin America, the Caribbean and Europe. We work with six of the ten biggest telecom groups to revolutionize the telecom and Consumer Goods industries.

Joolz

Private Equity Round in 2016
Joolz is a Netherlands-based company that specializes in the design and manufacture of premium pushchairs. Known for their award-winning products, Joolz emphasizes quality and ergonomic design, creating stylish and distinctive strollers that cater to the needs of both children and parents. The company's offerings include features such as detachable cradles, hypoallergenic mattresses, and four-wheel suspension, ensuring durability and ease of use for consumers. Joolz is committed to promoting a sustainable and healthy lifestyle for young families, which is evident in their use of reusable packaging and initiatives like the Joolz Birth Forest. Through their innovative products and focus on sustainability, Joolz aims to inspire families to enjoy a positive and enriching life.

Onward

Series A in 2016
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Contraload

Private Equity Round in 2016
Contraload is a fast growing Pan European company in pooling and rental services for plastic pallets and bins. For more than 10 years CLD has been focusing on plastic load carriers and has close to 1 million assets in its pool, all constantly on the move within the whole of Europe. CLD has a broad range of plastic pallets and IBCs for many different supply chains. Focus lies on the more complex food and FMCG supply chains with demanding and challenging global customers like Unilever, Nestle, Intersnack and many others. CLD helps its customers to meet the high quality and hygienic requirements, avoid foreign body contamination and to connect to suppliers or customers in a cost effective way. “CLD helps you carry the load”, so you can focus on your core business.

Itho Daalderop

Acquisition in 2016
Itho Daalderop develops and manufactures leading solutions in the fields of heating, tap water, ventilation and control technology. Innovative products and systems that contribute to a healthy, comfortable, energy efficient and affordable indoor climate.

Brakel

Acquisition in 2015
Brakel has been market leader in the area of daylight access, fire safety and ventilation solutions for more than 35 years, with sales in both Europe and further afield. And we offer integral solutions for all kinds of building types comprising: Daylight Skylights, rooflights, skylights and facades Fire safety SHEV systems, fire alarm systems, detection, compartmentation Ventilation Natural ventilation, controlled natural ventilation Maintenance SHEV and ventilation systems, fire alarm systems, glass constructions

Equipe Zorgbedrijven

Private Equity Round in 2015
Equipe Zorgbedrijven Holding B.V. is a healthcare service organization based in Eindhoven, the Netherlands, specializing in the operation of clinics for specialized surgery. The company manages a network of clinics, providing focused medical services to meet the needs of patients in the region.

CoScale

Venture Round in 2015
CoScale offers a comprehensive performance monitoring platform tailored for production environments, focusing on servers, containers, and applications. The platform provides continuous monitoring and assesses the impact of performance on user experience and essential business metrics. By utilizing automated anomaly detection and contextual insights, CoScale enables proactive management of performance fluctuations that could affect financial outcomes. Its user base includes DevOps engineers, application owners, and business managers, all seeking to enhance digital performance through faster and more reliable websites and applications. This leads to improved user experiences and increased conversion rates, positioning CoScale as a valuable tool for organizations aiming to optimize their digital infrastructure.

Itineris

Venture Round in 2015
Itineris specializes in developing and implementing UMAX, a cloud-based customer information and customer relationship management solution tailored for the utilities sector. UMAX utilizes workflow automation and artificial intelligence to facilitate comprehensive management of utility operations, encompassing functions such as revenue collection, asset management, and customer engagement. Built on the Microsoft Dynamics 365 platform and hosted in the Microsoft Azure Cloud, UMAX aims to streamline business processes for utility professionals. Since its founding in 2003, Itineris has established a strong track record in implementing its solutions across various clients, including notable organizations such as De Watergroep in Belgium, Eneco in the Netherlands, and the New York Department of Environmental Protection in the United States. The company focuses on empowering utility professionals to adapt to the evolving landscape of energy and water management.

United Dutch Breweries

Acquisition in 2015
United Dutch Breweries is an independent beer group, owning among others Oranjeboom, 3 Horses, Royal Dutch, Atlas – heritage brands, going back to the company’s origin. In addition, UDB sells specialty beers, such as non-alcoholic beers, stout beers and dark malt beverages.

EcoChem International

Acquisition in 2014
EcoChem develops and formulates eco-friendly flame retardants additives, which are mainly used in building & construction, transportation and electronic applications. The company’s products are added to materials such as wood, insulation, textiles or plastics in order to inhibit, suppress or delay flame and smoke production caused by fire. Headquartered in Olen (Belgium), EcoChem operates 2 production facilities located in Willlebroek (Belgium) and in Offenbach (Germany) and is serving clients in 25 countries.

Well Services Group

Private Equity Round in 2014
Well Services Group is a comprehensive service provider for the oil and gas industry, catering to both onshore and offshore operations. The company focuses on cleaning and regenerating existing oil and gas wells through the use of coiled tubing. Additionally, it offers installation services for plugs and measurement equipment within these wells. Well Services Group is committed to delivering high-quality services efficiently, utilizing state-of-the-art equipment and a team of experienced personnel. Its flexible operational approach allows for quick responses to customer needs across the petrochemical and energy sectors.

Ablynx

Grant in 2014
Ablynx is a biopharmaceutical company focused on the discovery and development of Nanobodies®, a unique class of therapeutic proteins derived from single-domain antibody fragments. These innovative proteins are designed to address a variety of serious human diseases, including inflammation, hematology, oncology, and pulmonary conditions. Currently, Ablynx has around 25 projects in its pipeline, with five Nanobodies in clinical development. By combining the advantages of traditional antibodies and small chemical molecules, Ablynx aims to provide new therapeutic options that can significantly improve patient care and outcomes.

Eurocept

Private Equity Round in 2013
Eurocept, an Ankeveen, the Netherlands-based healthcare company. Founded in 2001 by CEO Mike van Woensel, Eurocept sells specialized medicines and provides medical homecare services. Eurocept Pharmaceuticals is responsible for the registration, marketing, distribution and sale of speciality medicines in the fields of anesthetics, psychiatry, urology, pediatrics and infectious diseases. Eurocept Homecare provides medical specialist homecare and related out-patient medical technology for medicine and food administration.

NovoPolymers

Private Equity Round in 2013
NovoPolymers NV is a company focused on developing and producing sustainable solutions for the photovoltaic market. It specializes in creating front and back encapsulants designed to protect solar cells, which enhance the power output of both crystalline silicon and thin-film solar modules. By optimizing these encapsulants, NovoPolymers aims to add value throughout the photovoltaic supply chain, contributing to the efficiency and sustainability of solar energy production.

Complix

Series B in 2013
Complix is a biopharmaceutical company dedicated to the discovery and development of Alphabodies™, a new class of therapeutics designed to target challenging disease targets. These Alphabodies™ exhibit high affinity for a variety of disease targets, particularly those that are difficult to access with traditional antibodies or other protein-based therapies. The unique stability and versatility of Alphabodies™ allow for alternative non-injectable delivery methods, enhancing their potential in therapeutic applications. The company's pipeline focuses on intracellular targets significant in cancer, autoimmunity, and viral diseases, aiming to combine the effectiveness of biologics with the cell-penetrating capabilities and stability characteristic of small molecules.

Luciad

Acquisition in 2013
Luciad specializes in high-performance geospatial software services designed to support mission-critical operations across various sectors. The company's applications enhance the capabilities of developers and end users through advanced visual analytics, enabling them to leverage real-time location intelligence. Luciad's tools facilitate the development of next-generation geospatial systems applicable in areas such as public safety, smart cities, and defense. By providing intuitive command and control systems, the company allows users to make informed decisions based on dynamic information. Additionally, Luciad offers software solutions that integrate data with geographical information, including maps, satellite imagery, and terrain elevation in multiple formats.

Lampiris

Venture Round in 2013
Lampiris, an independent supplier of gas, green power and energy services such as insulation, furnace maintenance, wood and pellets for heating, and smart thermostats, has been active in the Belgian energy market since 2005. Lampiris, which currently supplies more than a million accounts, is the third-largest supplier in the residential energy market in Belgium.

Multiplicom

Venture Round in 2013
Multiplicom specializes in the development of molecular diagnostics products aimed at medical genetics and clinical laboratory applications. The company manufactures molecular diagnostic kits that facilitate the collection of genetic information, enabling personalized treatment options for patients. These kits are particularly valuable for early identification of congenital defects during pregnancy, thereby supporting effective and affordable healthcare solutions. Through its innovative products, Multiplicom strives to enhance access to personalized medicine in the field of genetics.

Biotalys

Venture Round in 2013
Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.

ARS Traffic & Transport Technology

Private Equity Round in 2012
ARS Traffic & Transport Technology has been providing traffic and transport technology solutions to businesses and government bodies since 1997. It is active in its home market of the Netherlands, but also internationally. The intelligent transport system market is always on the move, in every sense of the word. A dynamic market like this demands a specialised partner, able to cost-effectively integrate state-of-the-art, client-specific technology with existing systems, but also able to develop new hi-tech concepts.

NovoPolymers

Venture Round in 2012
NovoPolymers NV is a company focused on developing and producing sustainable solutions for the photovoltaic market. It specializes in creating front and back encapsulants designed to protect solar cells, which enhance the power output of both crystalline silicon and thin-film solar modules. By optimizing these encapsulants, NovoPolymers aims to add value throughout the photovoltaic supply chain, contributing to the efficiency and sustainability of solar energy production.

GreenWatt

Venture Round in 2012
GreenWatt is an established CleanTech company offering full engineering services, covering feasibility study conception, construction and starting up of turn key small scale biogas plants around innovative and unique patented technologies solving all key issues of anaerobic digestion.

Oldelft Ultrasound

Private Equity Round in 2012
Oldelft Ultrasound specializes in the manufacture of advanced transesophageal echocardiography (TEE) probes, serving as a vital supplier to global original equipment manufacturers (OEMs) of ultrasound systems. These systems are utilized in hospitals and medical institutions for diagnosing cardiovascular disorders. The company is particularly known for its innovative miniaturization of transducers, producing a range of high-quality probes for adult, pediatric, and neonatal cardio markets. Oldelft's product offerings include adult multiplane TEE transducers, mini-multi pediatric TEE transducers, micro multi TEE probes, and motorized adult multiplane TEE probes, all designed to provide superior imaging of the heart via the esophagus. The firm is also engaged in ongoing research and development projects in collaboration with various technical and medical universities, enhancing its expertise and product design capabilities.

Prosensa

Venture Round in 2012
Prosensa is a biotech company also known as Ribpharm Inc dedicated to the commercialization of products for the healthcare market based on RNA-based therapeutics. During the development of this technology, it became clear that many opportunities exist for the development of these products into novel commercially attractive products. These products are mainly in the field of genetic disorders, anti-infectives and oncology. Prosensa will focus to maximize the commercial development of the current program, and take advantage of the large novel market opportunities supported by a strong IP position. Prosensa will initially operate mainly as a focussed company, outsourcing most of its activities to specialized organizations.

Pronota

Series C in 2012
Pronota NV is a Belgian company specializing in the development and commercialization of innovative diagnostics aimed at the early detection of life-threatening conditions, such as heart failure, pre-eclampsia, and sepsis. The company utilizes a proprietary protein biomarker diagnostics platform that is non-invasive and validated, focusing on enhancing patient care and addressing unmet medical needs. Founded in 2004 and based in Zwijnaarde, Belgium, Pronota has garnered support from prominent investors and a network of key opinion leaders in the medical field. The firm was previously known as Peakadilly NV before rebranding in 2006.

VCST Industrial Products

Acquisition in 2011
VCST is a world-class automotive supplier of precision-machined powertrain and brake components for Automotive OEM’s and Tier 1 suppliers. The company realized a turnover of 169 million euro in 2015 and employs 1250 full time employees. VCST has production facilities in Belgium, China, Germany, Mexico and Romania, with its headquarters located in Belgium.

Trustteam

Private Equity Round in 2011
Trustteam NV is an information technology solutions provider based in Kortrijk, Belgium, with additional locations in Heusden-Zolder and Paris. Established in 2002, the company specializes in delivering a comprehensive range of IT services, including cloud solutions, software, hardware, security, telephony (VoIP), and auditing support. Trustteam focuses on managing the full spectrum of IT-related challenges for businesses, allowing clients to concentrate on their core operations while outsourcing their IT needs. The company's offerings also include consulting and digitization services, as well as security awareness training, catering to a diverse set of industries.

Studiekring

Private Equity Round in 2011
Studiekring is an educational service provider that offers targeted support for students in high school and the final years of primary school. The company focuses on addressing various challenges students may encounter, including difficulties with homework, time management, discipline, and motivation. Through its comprehensive suite of services, which includes tutoring, student coaching, educational programs, and examination training, Studiekring aims to enhance students' preparedness for their exams and overall academic success. By providing personalized guidance and training, Studiekring helps students build the skills and confidence necessary to excel in their studies.

XL Video

Venture Round in 2011
XL Video, an Ostend-belgim-based global player in the rental of video display systems for concerts, shows and other events. Founded in 1996 and led by CEO and co-founder René de Keijzer, XL Video is an international leading player in the rental of video technology, such as video screens, for major concert tours, trade fairs, TV shows, sports and other events. The group has a large stocks of high-end video technology such as video displays (LED, projection, plasma and LCD), HD camera systems and large trucks with built-in video screens. XL Video also develops and sells its own LED systems (Pixled).

Multiplicom

Venture Round in 2011
Multiplicom specializes in the development of molecular diagnostics products aimed at medical genetics and clinical laboratory applications. The company manufactures molecular diagnostic kits that facilitate the collection of genetic information, enabling personalized treatment options for patients. These kits are particularly valuable for early identification of congenital defects during pregnancy, thereby supporting effective and affordable healthcare solutions. Through its innovative products, Multiplicom strives to enhance access to personalized medicine in the field of genetics.

NovoPolymers

Series B in 2011
NovoPolymers NV is a company focused on developing and producing sustainable solutions for the photovoltaic market. It specializes in creating front and back encapsulants designed to protect solar cells, which enhance the power output of both crystalline silicon and thin-film solar modules. By optimizing these encapsulants, NovoPolymers aims to add value throughout the photovoltaic supply chain, contributing to the efficiency and sustainability of solar energy production.

NomaDesk

Series B in 2010
Nomadesk is a European SaaS company established in 2004 that specializes in business file sharing and synchronization technology. The company has developed a cloud-based platform that enables users to share, synchronize, and secure digital documents both online and offline. Its services are primarily targeted at small and medium-sized businesses, mobile professionals, resellers, service providers, and system integrators, who often rebrand Nomadesk solutions for their clients. Nomadesk maintains data center facilities in Europe and the United States to support its customer base in both regions. The company is part of UnifiedPost, which offers integrated business process optimization solutions, including document delivery, processing, and secure identity services.

Private Outlet

Venture Round in 2010
Private Outlet is the first-ever European shopping club specially designed for new trends, brands and fashion fanatics. Private Outlet organizes short sale events with some of the most famous brands around. There's up to 70% off the prices, but it's a 100% secure environment!

Liquavista

Series D in 2010
Liquavista B.V., a display manufacturing company, develops electro-wetting displays in the Netherlands and internationally. It offers LiquavistaBright that offers a combination of brightness in natural light and bold contrast to video; LiquavistaColor, which enables eReader devices to offer bright, full color, and low power video capable displays; and LiquavistaVivid, a transflective mode display, which represents the eReader application. Its products are used in portable and mobile applications, such as phones, watches, cameras, DVD players, and automotive applications. The company was founded in 2006 and is based in Eindhoven, the Netherlands with additional offices in the Netherlands, the United Kingdom, and Hong Kong.

GreenPeak Technologies

Series B in 2009
GreenPeak Technologies BV is a fabless semiconductor company based in Utrecht, the Netherlands, specializing in ultra-low power wireless data communication controller chips primarily for smart home applications and consumer electronics. Founded in 2004 and previously known as Xanadu Wireless, the company has established itself as a leader in the ZigBee market, offering a diverse range of RF chips and software technologies for Internet of Things (IoT) connectivity. GreenPeak's product lineup includes communication controller semiconductor products, transceiver chips, and modules designed for mesh networks and wireless sensor networks. Its solutions enable secure lifestyle information sharing among families, particularly for children and elderly parents. The company markets its products to original equipment manufacturers (OEMs) and original design manufacturers (ODMs) across the United States, Europe, Asia, and Latin America. GreenPeak also provides integration, support, and training services to its clients and has formed a strategic partnership with Sensara to enhance its offerings.

Pronota

Series B in 2009
Pronota NV is a Belgian company specializing in the development and commercialization of innovative diagnostics aimed at the early detection of life-threatening conditions, such as heart failure, pre-eclampsia, and sepsis. The company utilizes a proprietary protein biomarker diagnostics platform that is non-invasive and validated, focusing on enhancing patient care and addressing unmet medical needs. Founded in 2004 and based in Zwijnaarde, Belgium, Pronota has garnered support from prominent investors and a network of key opinion leaders in the medical field. The firm was previously known as Peakadilly NV before rebranding in 2006.

NovoPolymers

Series A in 2009
NovoPolymers NV is a company focused on developing and producing sustainable solutions for the photovoltaic market. It specializes in creating front and back encapsulants designed to protect solar cells, which enhance the power output of both crystalline silicon and thin-film solar modules. By optimizing these encapsulants, NovoPolymers aims to add value throughout the photovoltaic supply chain, contributing to the efficiency and sustainability of solar energy production.

Luma International

Series A in 2009
Luma International, founded in 2009, specializes in providing an on-demand marketing platform that enhances the capabilities of medium and large companies in creating personalized marketing materials efficiently. The platform, known for its user-friendly Digital Asset Management (DAM) and Enterprise Brand Management (EBM) solutions, supports diverse industries by enabling organizations like Toyota, Mercedes-Benz, and Coca-Cola to improve their marketing flexibility and campaign effectiveness while ensuring brand consistency. Luma's technology allows businesses to align their marketing strategies with sales objectives, providing better support for sales and marketing teams. The company, which has received several prestigious awards for its innovative solutions, operates offices in Antwerp, Rotterdam, Paris, and Redwood Shores.

Vandemoortele

Private Equity Round in 2009
Vandemoortele is a family-owned Belgian foods group with a European dimension. It manufactures and sells high-quality food products in two segments: frozen bakery products (Bakery Products) and margarines and fats (Lipids).

ActoGeniX

Private Equity Round in 2009
ActoGeniX is a biopharmaceutical company established in 2006 and headquartered in Zwijnaarde, Belgium. It focuses on the development and commercialization of a new generation of biological drugs utilizing a proprietary technology platform. This platform employs living non-pathogenic microorganisms for the oral delivery of biopharmaceuticals, addressing unmet needs in gastrointestinal, immunological, and metabolic diseases. Through its innovative approach, ActoGeniX aims to advance therapeutic options in these critical areas of healthcare.

Prosensa

Series B in 2008
Prosensa is a biotech company also known as Ribpharm Inc dedicated to the commercialization of products for the healthcare market based on RNA-based therapeutics. During the development of this technology, it became clear that many opportunities exist for the development of these products into novel commercially attractive products. These products are mainly in the field of genetic disorders, anti-infectives and oncology. Prosensa will focus to maximize the commercial development of the current program, and take advantage of the large novel market opportunities supported by a strong IP position. Prosensa will initially operate mainly as a focussed company, outsourcing most of its activities to specialized organizations.

Clear2Pay

Venture Round in 2008
Clear2Pay is a payments technology company that specializes in electronic payment services. Its Open Payment Framework (OPF) allows financial institutions to enhance their internal payments processing efficiencies while offering clients faster payment services enriched with detailed information. This framework operates on a Service-Oriented Architecture (SOA), enabling banks to utilize a centralized payments engine with a library of reusable business services applicable across all payment types. By integrating new service models with existing infrastructures, Clear2Pay helps banks protect their previous investments and transition to a more modern and efficient payments environment. Additionally, the company provides a Software Development Kit and a Bank Payment Hub, which facilitates customer interaction, order management, and payment execution, along with services for dispute and exception processing.

Viabuild

Private Equity Round in 2008
Viabuild is an integrated contracting company based in Belgium, specializing in road building, civil construction, and drainage works. The firm serves both public and private sectors, focusing on a range of services including the construction of roads, squares, and parking garages, as well as earthmoving, surfacing, demolition, excavation, and sewer renovation. Viabuild is dedicated to meeting the diverse needs of its clients by providing tailored solutions for various infrastructure projects.

Liquavista

Series B in 2008
Liquavista B.V., a display manufacturing company, develops electro-wetting displays in the Netherlands and internationally. It offers LiquavistaBright that offers a combination of brightness in natural light and bold contrast to video; LiquavistaColor, which enables eReader devices to offer bright, full color, and low power video capable displays; and LiquavistaVivid, a transflective mode display, which represents the eReader application. Its products are used in portable and mobile applications, such as phones, watches, cameras, DVD players, and automotive applications. The company was founded in 2006 and is based in Eindhoven, the Netherlands with additional offices in the Netherlands, the United Kingdom, and Hong Kong.

Diatos

Series D in 2007
Diatos is a biopharmaceutical company founded in 1999 and headquartered in Paris, France with two subsidiaries in Leuven, Belgium and in the San Francisco Bay Area, USA. Diatos is focused on the research, development and marketing of new versions of existing anti-cancer chemotherapeutic drugs with enhanced tumor targeting or improved biodistribution. Diatos has built its portfolio of drugs and drug candidates through a strategy of license acquisitions as well as an internal research and development activity based on its prodrug technologies, Vectocell® and Tumor-Selective Prodrug (TSP).

NomaDesk

Series A in 2007
Nomadesk is a European SaaS company established in 2004 that specializes in business file sharing and synchronization technology. The company has developed a cloud-based platform that enables users to share, synchronize, and secure digital documents both online and offline. Its services are primarily targeted at small and medium-sized businesses, mobile professionals, resellers, service providers, and system integrators, who often rebrand Nomadesk solutions for their clients. Nomadesk maintains data center facilities in Europe and the United States to support its customer base in both regions. The company is part of UnifiedPost, which offers integrated business process optimization solutions, including document delivery, processing, and secure identity services.

ActoGeniX

Venture Round in 2007
ActoGeniX is a biopharmaceutical company established in 2006 and headquartered in Zwijnaarde, Belgium. It focuses on the development and commercialization of a new generation of biological drugs utilizing a proprietary technology platform. This platform employs living non-pathogenic microorganisms for the oral delivery of biopharmaceuticals, addressing unmet needs in gastrointestinal, immunological, and metabolic diseases. Through its innovative approach, ActoGeniX aims to advance therapeutic options in these critical areas of healthcare.

Movetis

Series A in 2007
Movetis NV, a pharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company's lead product, Resolor, is used for the symptomatic treatment of chronic constipation in women. Resolor is also tested for chronic constipation in males and children, as well as opioid-induced constipation and post operative ileus. Its products also include M0002, which is in Phase II trials to treat ascites, an accumulation of fluid caused by liver malfunction; and M0003 that is entering Phase II development for symptomatic treatment of heartburn and regurgitation in patient's refractory to PPIs, and pediatric reflux. In addition, the company also has two prioritized compounds out of its preclinical portfolio, M0014 and M0012, and two compound libraries. It has partnership agreements with the universities of Ghent, Leuven, and Rotterdam. The company was founded in 2006 and is headquartered in Turnhout, Belgium.

Liquavista

Series A in 2006
Liquavista B.V., a display manufacturing company, develops electro-wetting displays in the Netherlands and internationally. It offers LiquavistaBright that offers a combination of brightness in natural light and bold contrast to video; LiquavistaColor, which enables eReader devices to offer bright, full color, and low power video capable displays; and LiquavistaVivid, a transflective mode display, which represents the eReader application. Its products are used in portable and mobile applications, such as phones, watches, cameras, DVD players, and automotive applications. The company was founded in 2006 and is based in Eindhoven, the Netherlands with additional offices in the Netherlands, the United Kingdom, and Hong Kong.

Accent Jobs for People

Private Equity Round in 2006
Accent Jobs for People NV is a recruitment agency based in Roeselare, Belgium, specializing in temporary employee recruitment and leasing services. Founded in 1995, the company has established a significant presence in the Belgian temporary labor market within a decade. Accent Jobs for People offers employment opportunities across various sectors, including construction, engineering, production, sales and marketing, logistics and distribution, and tourism, among others.

Ablynx

Series C in 2006
Ablynx is a biopharmaceutical company focused on the discovery and development of Nanobodies®, a unique class of therapeutic proteins derived from single-domain antibody fragments. These innovative proteins are designed to address a variety of serious human diseases, including inflammation, hematology, oncology, and pulmonary conditions. Currently, Ablynx has around 25 projects in its pipeline, with five Nanobodies in clinical development. By combining the advantages of traditional antibodies and small chemical molecules, Ablynx aims to provide new therapeutic options that can significantly improve patient care and outcomes.

Pronota

Series A in 2006
Pronota NV is a Belgian company specializing in the development and commercialization of innovative diagnostics aimed at the early detection of life-threatening conditions, such as heart failure, pre-eclampsia, and sepsis. The company utilizes a proprietary protein biomarker diagnostics platform that is non-invasive and validated, focusing on enhancing patient care and addressing unmet medical needs. Founded in 2004 and based in Zwijnaarde, Belgium, Pronota has garnered support from prominent investors and a network of key opinion leaders in the medical field. The firm was previously known as Peakadilly NV before rebranding in 2006.

Clear2Pay

Series D in 2006
Clear2Pay is a payments technology company that specializes in electronic payment services. Its Open Payment Framework (OPF) allows financial institutions to enhance their internal payments processing efficiencies while offering clients faster payment services enriched with detailed information. This framework operates on a Service-Oriented Architecture (SOA), enabling banks to utilize a centralized payments engine with a library of reusable business services applicable across all payment types. By integrating new service models with existing infrastructures, Clear2Pay helps banks protect their previous investments and transition to a more modern and efficient payments environment. Additionally, the company provides a Software Development Kit and a Bank Payment Hub, which facilitates customer interaction, order management, and payment execution, along with services for dispute and exception processing.

GreenPeak Technologies

Venture Round in 2006
GreenPeak Technologies BV is a fabless semiconductor company based in Utrecht, the Netherlands, specializing in ultra-low power wireless data communication controller chips primarily for smart home applications and consumer electronics. Founded in 2004 and previously known as Xanadu Wireless, the company has established itself as a leader in the ZigBee market, offering a diverse range of RF chips and software technologies for Internet of Things (IoT) connectivity. GreenPeak's product lineup includes communication controller semiconductor products, transceiver chips, and modules designed for mesh networks and wireless sensor networks. Its solutions enable secure lifestyle information sharing among families, particularly for children and elderly parents. The company markets its products to original equipment manufacturers (OEMs) and original design manufacturers (ODMs) across the United States, Europe, Asia, and Latin America. GreenPeak also provides integration, support, and training services to its clients and has formed a strategic partnership with Sensara to enhance its offerings.

Gemidis

Series C in 2006
Gemidis is a spin-off company from Ghent University (Belgium) and IMEC (Belgium) and was officially founded in August 2004. Gemidis develops, produces and sells LCOS imagers and driver electronics for both consumer and professional markets.

Operator Group Delft

Acquisition in 2006
OGD provides ICT services in the fields of infrastructure, end-user management, and software development. They provide outsourcing, projects, advice, and ICT professionals. They provides services for ICT professionals, ICT solutions, outsource IT, ICT training and ICT advice.

Ablynx

Series B in 2004
Ablynx is a biopharmaceutical company focused on the discovery and development of Nanobodies®, a unique class of therapeutic proteins derived from single-domain antibody fragments. These innovative proteins are designed to address a variety of serious human diseases, including inflammation, hematology, oncology, and pulmonary conditions. Currently, Ablynx has around 25 projects in its pipeline, with five Nanobodies in clinical development. By combining the advantages of traditional antibodies and small chemical molecules, Ablynx aims to provide new therapeutic options that can significantly improve patient care and outcomes.

PamGene

Series B in 2003
PamGene is a biotechnology company that specializes in a proprietary array-based platform designed to measure the activities of kinases and nuclear receptors. This technology enhances the understanding of drug interactions with these critical signaling molecules. PamGene's platform has diverse applications, including lead identification and optimization, clinical translational research, and biomarker development, particularly in the fields of oncology and medicine. The company's focus is on measuring the activities of tyrosine and serine-threonine kinases, alongside nuclear receptors, while also providing software tools for data analysis. This enables researchers to discover and develop medicines that can inhibit or modulate cellular kinases and their associated pathways.

Ablynx

Series A in 2002
Ablynx is a biopharmaceutical company focused on the discovery and development of Nanobodies®, a unique class of therapeutic proteins derived from single-domain antibody fragments. These innovative proteins are designed to address a variety of serious human diseases, including inflammation, hematology, oncology, and pulmonary conditions. Currently, Ablynx has around 25 projects in its pipeline, with five Nanobodies in clinical development. By combining the advantages of traditional antibodies and small chemical molecules, Ablynx aims to provide new therapeutic options that can significantly improve patient care and outcomes.

ORMvision

Series B in 2001
ORMvision is a provider of Business Process Management software solutions for telecoms operators.

PamGene

Series A in 2000
PamGene is a biotechnology company that specializes in a proprietary array-based platform designed to measure the activities of kinases and nuclear receptors. This technology enhances the understanding of drug interactions with these critical signaling molecules. PamGene's platform has diverse applications, including lead identification and optimization, clinical translational research, and biomarker development, particularly in the fields of oncology and medicine. The company's focus is on measuring the activities of tyrosine and serine-threonine kinases, alongside nuclear receptors, while also providing software tools for data analysis. This enables researchers to discover and develop medicines that can inhibit or modulate cellular kinases and their associated pathways.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.